Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety Study of Recombinant Human Alpha-mannosidase for the Treatment of Patients With Alpha-mannosidosis
This study has been completed.
Study NCT01268358   Information provided by Zymenex A/S

First Received on December 29, 2010.   Last Updated on May 6, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Alpha Mannosidosis
Additional conditions recognized in this trial
Alpha-Mannosidosis
Mannosidase Deficiency Diseases
More general conditions related to this trial
Carbohydrate Metabolism, Inborn Errors
Genetic Diseases, Inborn
Lysosomal Storage Diseases
Metabolic Diseases
Metabolism, Inborn Errors
Interventions listed in this trial
Lamazym
Sponsors listed in this trial
Zymenex A/S
European Commission


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services